DRAP seeks pharma companies promotional activities' data.

LAHORE -- The Drugs Regulatory Authority Pakistan (DRAP) has asked all pharmaceutical companies to submit their expenditure data regarding promotional activities including sampling for the last two years, from 2017 to 2019.

As per Rule 33 (related to registration, licensing and advertisement) of the Drugs Act 1976, no pharmaceutical firm/company should spend more than five per cent of their turnover on advertisement, sampling to prescribers and other promotional activities in respect of drugs.

DRAP has issued a notification in this regard, seeking record of pharma companies for the last two years, so that an audit of the record could be done to check misappropriation in allocation of more than five per centturnover.

The country's aelophathic medicines market consists of around $.12 billion per annum in which 38 per cent shareholders are multinational companies.

Meanwhile, a...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT